Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.
Liver fibrosis is characterized by excessive synthesis of extracellular matrix proteins, which prevails over their enzymatic degradation, primarily by matrix metalloproteinases (MMPs). The effect of pharmacological MMP inhibition on fibrogenesis, however, is largely unexplored. Inflammation is consi...
Main Authors: | Vincent E de Meijer, Deanna Y Sverdlov, Yury Popov, Hau D Le, Jonathan A Meisel, Vânia Nosé, Detlef Schuppan, Mark Puder |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2892485?pdf=render |
Similar Items
-
Macrophages and platelets in liver fibrosis and hepatocellular carcinoma
by: Martina Casari, et al.
Published: (2023-12-01) -
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
by: Leonard Kaps, et al.
Published: (2020-09-01) -
Matrix Metalloproteinase’s Role in Producing and Curing of Liver Fibrosis
by: Hossein Baharvand, et al.
Published: (2009-01-01) -
The Metabolomic Footprint of Liver Fibrosis
by: Diren Beyoğlu, et al.
Published: (2024-08-01) -
Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis
by: Ping An, et al.
Published: (2020-05-01)